Guru Ownership Trend
Guru Analysis for Fate Therapeutics, Inc. (FATE)
Fate Therapeutics, Inc. (FATE), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q2 2026, a total of 5 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $22.11 M.
Top institutional holders include Cliff Asness and Renaissance Technologies (RenTech).
Institutional sentiment is currently Bullish. This is evidenced by a $4.06 M net inflow during the quarter.
Recent activity highlights Steven Cohen who increased their stake by 925.6%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q2 2026)
Guru Consensus (Q2 2026)
FAQs for Fate Therapeutics, Inc. (FATE)
Major holders include Cliff Asness ($10.36 M), Renaissance Technologies (RenTech) ($8.05 M), Robert Bruce ($2.67 M). According to the latest reported data, 5 tracked investment managers collectively hold approximately 8.31 M shares.
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $4.06 M, with 5 managers increasing positions and 0 managers reducing holdings.
No tracked managers reduced or fully exited their positions in FATE during the most recent reporting period.
Yes, 1 managers opened new positions in FATE, and 4 increased their existing holdings. The total reported buy value was $4.06 M.